Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
Haematology nurses, pharmacists, and other HCPs involved in the care of patients receiving bispecific antibodies are invited to attend a dedicated training session at the KOL Haematology Research & Strategy Forum.
This free, interactive session will focus on enhancing clinical practice and confidence in managing BsAbs across myeloma and lymphoma settings. Topics include administration essentials, monitoring, managing side effects such as CRS and ICANs, and applying evidence-based strategies for early intervention and escalation.
Held alongside the Haematology Patients and Carers Congress (HPCC), this event provides an excellent opportunity for professional development and peer collaboration.
–
